Drug Type Unknown |
Synonyms- |
Target |
Action inhibitors |
Mechanism PDE1B inhibitors(phosphodiesterase 1B inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dyskinesias | Preclinical | United States | 01 Mar 2026 | |
| Mild cognitive disorder | Preclinical | United States | 01 Mar 2026 | |
| Parkinson Disease | Preclinical | United States | 01 Mar 2026 |





